SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

08 Nov 2023 Evaluate
The company witnessed a 7.50% growth in the revenue at Rs. 4796.98 millions for the quarter ended September 2023 as compared to Rs. 4462.21 millions during the year-ago period.Good  Net Profit growth of 40.50% reported above the corresponding previous quarter figure of Rs. 512.76 millions to Rs. 720.41 millioins.Operating profit for the quarter ended September 2023 rose to 1060.95 millions as compared to 797.60 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 4796.98 4462.21 7.50 10097.38 9392.29 7.51 17770.32 15189.65 16.99
Other Income 273.85 286.31 -4.35 571.69 480.30 19.03 539.12 787.34 -31.53
PBIDT 1060.95 797.60 33.02 2558.85 1791.78 42.81 3084.87 3255.80 -5.25
Interest 10.51 10.11 3.96 20.89 17.07 22.38 40.39 30.48 32.51
PBDT 1050.44 787.49 33.39 2537.96 1774.71 43.01 3044.48 3225.32 -5.61
Depreciation 98.13 99.38 -1.26 194.01 192.55 0.76 387.58 370.81 4.52
PBT 952.31 688.11 38.40 2343.95 1582.16 48.15 2656.90 2854.51 -6.92
TAX 231.90 175.35 32.25 538.03 339.21 58.61 647.25 658.15 -1.66
Deferred Tax 16.71 -7.65 -318.43 17.84 -86.79 -120.56 -42.75 -21.85 95.65
PAT 720.41 512.76 40.50 1805.92 1242.95 45.29 2009.65 2196.36 -8.50
Equity 162.81 165.91 -1.87 165.91 165.91 0.00 165.91 168.81 -1.72
PBIDTM(%) 22.12 17.87 23.73 25.34 19.08 32.84 17.36 21.43 -19.01

FDC Share Price

358.65 2.60 (0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×